A phase 2 liver trial where the add-on drug didn't help — and the base drug quietly did
Read the Sunday Brief →
Cosmetic octapeptide (acetyl octapeptide-3) · 8 aa

SNAP-8

Acetyl octapeptide-3, a topical cosmetic peptide

SNAP-8, known chemically as acetyl octapeptide-3, is a synthetic topical cosmetic peptide used in leave-on skincare formulations marketed for the appearance of expression lines around the forehead and eyes. It is often described in cosmetic-industry materials as a needle-free, "Botox-like" alternative, positioned as a milder extension of the earlier hexapeptide acetyl hexapeptide-8 (Argireline). It is a cosmetic ingredient, not a drug, and is intended for surface application rather than injection. Most of the claims attached to it originate from the ingredient's manufacturers and cosmetic testing rather than independent clinical medicine.

This page is editorial content summarising reported literature. It does not constitute medical advice and should not be used to guide treatment decisions. Nothing on this page states that any substance cures, treats, or prevents any condition.
Safety first

Side effects & risks

Topical SNAP-8 is generally reported in cosmetic contexts as low-irritation and well tolerated on the skin, but honest data on safety are limited. As with any leave-on skincare ingredient, local reactions are possible, including redness, stinging, itching, or contact irritation, and allergic sensitization cannot be ruled out for any given individual. Systemic safety data are effectively absent, and the consequences of use on broken skin, in pregnancy, or in nursing have not been characterized. This ingredient is formulated for topical application only and is not intended for injection under any circumstances. Individuals with sensitive skin, active dermatologic conditions, or known peptide or fragrance allergies should be especially cautious. A patch test before broader use is a sensible precaution, and anyone with concerns should consult a dermatologist. Because independent safety literature is sparse, the absence of reported harm should not be read as proof of safety.

02

Latest studies

No studies indexed yet for this peptide.

04

Reported protocols (with caveats)

⚠ Editor's caveat
These dose ranges describe what people are reported to do, not what is established as safe or effective. There is no FDA-approved indication. Self-injection of unscheduled peptides carries known and unknown risks. Talk to a clinician.

In cosmetic use, SNAP-8 is reported as an ingredient within leave-on formulations such as serums, creams, and eye products rather than as a standalone regimen. Supplier documentation commonly describes use concentrations in the range of roughly 1 to 10 percent of a finished formulation, with lower percentages typical in complete consumer products. It is reported to be applied topically to areas prone to expression lines, such as the forehead and around the eyes, usually once or twice daily as part of a routine. It is sometimes combined with other cosmetic peptides in the same product. These figures reflect reported cosmetic-industry formulation practice and are not medical dosing guidance or a recommendation.